West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 51.9 0 (0%) Market Cap: 131.56 Bil Enterprise Value: 130.48 Bil PE Ratio: 46.70 PB Ratio: 8.29 GF Score: 92/100

West Pharmaceutical Services Inc at KeyBanc Capital Markets Life Sciences & Medtech Investor Forum (virtual) Transcript

Mar 24, 2021 / 02:00PM GMT
Paul Richard Knight
KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst

Good morning. This is Paul Knight, the analyst following West Pharmaceutical. I cover the life science technology industry at Keybank. We have today West Pharmaceutical presenting. Eric Green, CEO; Bernard Birkett, CFO; and Quintin Lai, Director of Investor Relations as well. We thank the management team for their time. And we'll have a quick overview from the company. We'll open it up for Q&A. I'll start it, but the bottom in your screens, there is a space for you to enter questions, I'll take those questions and get them to the management team as well.

So with that, Eric, I'll let you start.

Eric M. Green
West Pharmaceutical Services, Inc. - President, CEO & Director

Great. Thank you, Paul. And first of all, thank you for the invitation to the event. I truly appreciate that. What we'll do is I'll give you a brief overview, but then excited to get into the Q&A, because I know there's probably a lot of good questions to address. So first of all,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot